Every 15 minutes, a child is born with a congenital heart defect (CHD). These children often need multiple surgeries to treat their condition — sometimes before their first birthday.
At Renata, we are focused on serving these unmet congenital needs by delivering safe and adaptable solutions designed for a lifetime of growth. In partnership with world-renowned physicians who dedicate their lives to treating children with CHD, Renata is driven to develop transformational solutions for young CHD patients that are designed to adapt and grow alongside them.
To Innovate, Develop, And Market Solutions
For Unmet Pediatric Needs.
CO-FOUNDER AND CHIEF EXECUTIVE OFFICER
For nearly two decades, Dustin worked and managed teams in the Transcatheter Aortic, Transcatheter Pulmonic, and Tricuspid device spaces at Edwards Lifesciences. He has ample experience innovating and leading concepts from conceptualization to first-in-market solutions through commercialization.
Dustin attended Purdue University where he obtained a degree in Mechanical Engineering.
CO-FOUNDER AND CHIEF OPERATING OFFICER
Eason started his career at Edwards Lifesciences focusing on Transcatheter Pulmonic & Tricuspid devices. With over 10 years of professional experience, he has become well versed in designing and implementing delivery systems and implants with a focus on the pediatric space.
Eason attended Duke University where he obtained a degree in Biomedical Engineering.
CHIEF MEDICAL OFFICER
A world-renowned pediatric interventional cardiologist, Dr. Zahn has spent over 30 years designing and pioneering advanced procedures to treat congenital defects in premature babies and adults. Over his career, he has treated thousands of newborns with congenital heart disease.
Dr. Zahn currently resides in Los Angeles where he is the director of pediatric cardiology at the Guerin Family Congenital Heart Program at Cedars-Sinai.
President, City of Hope
Board Member
Former Executive, Medtronic
Board Member
General Partner, SC Master Fund
Board Member
Special Advisor
Special Advisor
Special Advisor
New Device Studied at Cedars-Sinai Means Fewer Heart Surgeries for Babies
Learn More